Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
<p><strong>Aims</strong> Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains uncertain whether there is clinically relevant genetic variation in their efficacy. This study of 18 705 individuals aims to identify genetic variants related to the lipi...
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Langue: | English |
| Publié: |
Oxford University Press
2013
|